HDG presentation_pathogenic mechanisms of DIHA
-
Upload
truc-nguyen-tamia -
Category
Documents
-
view
80 -
download
0
Transcript of HDG presentation_pathogenic mechanisms of DIHA
Biological mechanisms of Drug-induced haemolytic anaemia
(DIHA)
Tamia NguyenHaematology Discussion
Group 26/07/2016
Outline• Why talk about DIHA?• The proposed biological mechanisms of DIHA
Drug-induced immune haemolytic anaemia • A blood disorder that occurs when a drug triggers the
body’s immune system to attack its own red cells.
• DIHA is Rare – ~12% IHA
• But:– Can be under-recognised
• Similar serological features as IHA by other causes
– Potentially life-threatening if left untreated – Haemolysis resolved rapidly upon drug cessation
The proposed mechanisms of DIHA– Less emphasised area but interesting– Sufficient data to call for a reclassification– Some freaky behaviours
Traditional mechanisms:– Drug dependent Ab: only react in the
presence of drug• Hapten hypothesis• Immune complex hypothesis
– Drug independent Ab: true autoAb• Altered self antigen hypothesis• Immune dysregulation hypothesis
– Non-immunological protein adsorption
UNIFYING HYPOTHES
IS
Hapten hypothesis1. Drug firmly attaches to RBC membrane
2. Membrane-bound drug elicits an immune response
Prototype drug: penicillin – covalently bind RBC
Limitation: Most drugs do not form stable bond with RBC
Immune complex hypothesis
1. The body produces Ab against the drug
2. Antibodies binds to drug and form an immune complex
3. The complex adsorbs to RBC membrane and activate C’
Prototype drug: quinidineLimitations: - Drug-antibody complexes have never been demonstrated experimentally- Ab binds RBC via their FAB domain - Ab appear to be cell line-specific
1. DAT doesn’t become positive until 3-6 months after drug 2. Haemolysis can take up to 4 months to develop but
resolves quickly after drug cessation (~2 weeks)3. Seemingly no immune memory when patient is
rechallenged with drug ie again, take long time to develop Ab
4. Codevelopment of other autoantibodies (anti-nuclear Ab, lupus-like syndrome)
Prototype drug: methyldopa (Aldomet)
Drug independent Antibodies have some unusual features
Altered self antigen hypothesis Immune dysregulation hypothesis
- Drugs alters RBC antigen in a way that they are no longer recognised as self
- Can explain: The delay in DAT becoming positive if drug is incorporated into normoblasts or retics
- Cannot explain: Everything else Plus, binding between Methyldopa and RBC has never been demonstrated consistently
- Methyldopa cause an aberration in lymphocyte proliferation, allowing proliferation of auto-Ab producing cells.
- Can explain: almost everything: a delay in DAT change, delay in haemolysis, even in repeated challenge
- However:Experiments that supported this hypothesis could not be reproducedFurther studies yield inconclusive or contradicting conclusions.
Unifying hypothesis1. Drug first interact with the cell membrane2. Then, this drug-membrane structure can induce
the production of drug-dependent or drug-independent Ab
Limitation:- Many drug only provoke one type of Ab: drug-dependent
OR drug-independent- Fail to explain the co-development of other autoAb
Non-immunological protein adsorption
Drug modifies RBC membrane so that normal plasma proteins are non-specifically adsorbed onto the red cell.
Traditionally thought to cause positive DAT but not haemolysis BUT now shown to also cause haemolysis (if IgG is absorbed) Prototype drug: cephalosporinLimitation: limited study
SummaryTraditional mechanisms:– Drug dependent Ab• Hapten hypothesis• Immune complex hypothesis
– Drug independent Ab• Altered self antigen hypothesis• Immune dysregulation hypothesis
– Non-immunological protein adsorption Many difficulties in studying DIHA…
UNIFYING HYPOTHESIS
Supplementary slides
Serological characteristicsDrug-dependent Ab Drug-independent Ab
Penicillin-type Non-penicillin type Methyldopa-induced AutoAb
NIPA
Require large dose of drug
Require a small amount of drugs
10-30% develop pos DAT but only 0.5% develop HA
positive DAT but rarely haemolysis
Develop over 7-10 days
Acute onset, many patients have renal failure
Develop up to months after therapy
DAT +, usually with IgG
IAT ±, elution suggestive but not characteristics
DAT +, usually with C’
IAT ±, elution suggestive but not characteristics
DAT + with IgG
IAT , eluate (indistinguishable from WAIHA)
DAT + with multiple proteins on RBC (eg: albumin)IAT , eluate
High titre of penicillin Ab in the serum (~1000)